theophylline and levofloxacin

Levofloxacin inhibits the hepatic cytochrome P450 enzyme CYP1A2, which is primarily responsible for the metabolism of theophylline. This inhibition reduces theophylline clearance, leading to elevated serum theophylline concentrations.

Increased theophylline levels can cause signs of toxicity, including nausea, vomiting, tremors, palpitations, tachycardia, and in severe cases, seizures or cardiac arrhythmias. The onset may occur within days of starting levofloxacin.

Avoid concomitant use if possible. If co-prescription is necessary, monitor serum theophylline levels closely (e.g., before starting and within 1-2 days after adding levofloxacin) and reduce the theophylline dose as needed. Monitor the patient for clinical signs of theophylline toxicity. Consider an alternative antibiotic with less interaction potential, such as azithromycin; ciprofloxacin is itself a potent CYP1A2 inhibitor and is not an alternative.

This interaction is well-established and documented in multiple sources, including the British National Formulary and various drug interaction databases. Reports of increased theophylline levels and toxicity with levofloxacin are consistent. However, the magnitude of the effect can vary between individuals, so close monitoring is essential.